Clinical Trial Update: Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806 [Phase 3]

View source ↗

Summary

This update reports Phase 3 pediatric data on the efficacy and long-term safety of adalimumab in Crohn's disease for patients who previously demonstrated a clin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Crohn's Disease | Phase 3 | Status: COMPLETED | Results posted: 2018-04-20